Xuebing Di
- Topics
- Cancer-related molecular mechanisms research (5 papers)Ferroptosis and cancer prognosis (4 papers)RNA modifications and cancer (4 papers)
- Cited by
- Cancer ResearchImmunologyOncology
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Xuebing Di
24 papers receiving 692 citations
Peers
Comparison fields: 5 of 66
- Molecular Biology 355
- Cancer Research 226
- Oncology 197
- Pulmonary and Respiratory Medicine 175
- Immunology 164
Countries citing papers authored by Xuebing Di
This map shows the geographic impact of Xuebing Di's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuebing Di with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuebing Di more than expected).
Fields of papers citing papers by Xuebing Di
This network shows the impact of papers produced by Xuebing Di. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuebing Di. The network helps show where Xuebing Di may publish in the future.
Co-authorship network of co-authors of Xuebing Di
This figure shows the co-authorship network connecting the top 25 collaborators of Xuebing Di. A scholar is included among the top collaborators of Xuebing Di based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuebing Di. Xuebing Di is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 133 | |
| 2 | 11 | |
| 3 | 5 | |
| 4 | 5 | |
| 5 | 32 | |
| 6 | 25 | |
| 7 | 30 | |
| 8 | 23 | |
| 9 | 5 | |
| 10 | 52 | |
| 11 | 11 | |
| 12 | 26 | |
| 13 | 57 | |
| 14 | 11 | |
| 15 | 7 | |
| 16 | 49 | |
| 17 | [DNA microarrays-based microRNA expression profiles derived from formalin-fixed paraffin-embedded tissue blocks of squammous cell carcinoma of larynx]. | 7 |
| 18 | 17 | |
| 19 | [Loss of heterozygosity fine mapping of chromosome 17p13 in transitional cell carcinoma of human urinary bladder]. | 1 |
| 20 | 12 |
About Xuebing Di
Xuebing Di is a scholar working on Cancer Research, Oncology and Immunology, having authored 24 papers that have together received 700 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), Ferroptosis and cancer prognosis (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Cancer Research (226 citations), Immunology (164 citations) and Oncology (197 citations). Xuebing Di has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Lin Feng, Ting Xiao, Kaitai Zhang, Shujun Cheng, Naijun Han, Yanning Gao, Liping Guo, Jianzhong Shou, Yi Zhang and Yipeng Wang. Their work appears in journals such as Nucleic Acids Research, PLoS ONE and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.